chr12-53307457-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The ENST00000548931.6(AAAS):c.*33C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0019 in 1,574,330 control chromosomes in the GnomAD database, including 51 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0033 ( 7 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 44 hom. )
Consequence
AAAS
ENST00000548931.6 3_prime_UTR
ENST00000548931.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.552
Genes affected
AAAS (HGNC:13666): (aladin WD repeat nucleoporin) The protein encoded by this gene is a member of the WD-repeat family of regulatory proteins and may be involved in normal development of the peripheral and central nervous system. The encoded protein is part of the nuclear pore complex and is anchored there by NDC1. Defects in this gene are a cause of achalasia-addisonianism-alacrima syndrome (AAAS), also called triple-A syndrome or Allgrove syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 12-53307457-G-A is Benign according to our data. Variant chr12-53307457-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 309717.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00333 (508/152332) while in subpopulation SAS AF= 0.0319 (154/4828). AF 95% confidence interval is 0.0278. There are 7 homozygotes in gnomad4. There are 285 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AAAS | NM_015665.6 | downstream_gene_variant | ENST00000209873.9 | ||||
AAAS | NM_001173466.2 | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AAAS | ENST00000209873.9 | downstream_gene_variant | 1 | NM_015665.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00330 AC: 503AN: 152214Hom.: 7 Cov.: 33
GnomAD3 genomes
AF:
AC:
503
AN:
152214
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00422 AC: 896AN: 212488Hom.: 16 AF XY: 0.00513 AC XY: 588AN XY: 114692
GnomAD3 exomes
AF:
AC:
896
AN:
212488
Hom.:
AF XY:
AC XY:
588
AN XY:
114692
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00175 AC: 2483AN: 1421998Hom.: 44 Cov.: 33 AF XY: 0.00238 AC XY: 1681AN XY: 706768
GnomAD4 exome
AF:
AC:
2483
AN:
1421998
Hom.:
Cov.:
33
AF XY:
AC XY:
1681
AN XY:
706768
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00333 AC: 508AN: 152332Hom.: 7 Cov.: 33 AF XY: 0.00383 AC XY: 285AN XY: 74488
GnomAD4 genome
AF:
AC:
508
AN:
152332
Hom.:
Cov.:
33
AF XY:
AC XY:
285
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
54
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Glucocorticoid deficiency with achalasia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at